Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

Inclusion Criteria: * Histologically or pathologically confirmed primary diagnosis of stage I-IV ovarian, primary peritoneal, or fallopian tube cancer (any cell type) * Planning to receive ≥ 6 courses of front-line chemotherapy * Have not yet received the first course of chemotherapy * GOG performance status 0-2 * Able to read and understand English * No uncontrolled or severe cardiovascular disease, including any of the following: * Myocardial infarction within the past year * Uncontrolled hypertension * Congestive heart failure * No history of head injury with GCS \< 13 * No severe hemiparesis or other condition preventing bimanual keyboard operation * No distal neuropathy, action tremor, or other motor dysfunction that would substantially decrease keyboard accuracy * No severe motor or mental slowing (i.e., patient who is disoriented/level C on any criterion as assessed by the person-place-time criteria) * No other invasive malignancies within the past 5 years except for nonmelanoma skin cancer * More than 6 months since prior epoetin alfa, darbepoetin, or any investigational forms of erythropoietin * Patients may receive these agents during chemotherapy treatment as needed * No prior radiotherapy or chemotherapy